ବ୍ଲଡ କ୍ୟାନସର: ଷ୍ଟେମ ସେଲ୍ ଟ୍ରାନ୍ସପ୍ଲାଣ୍ଟ

Cyclophosphamide is the name of a medicine given to prevent graft-versus-host-disease (GVHD) after half-matched transplant. This medicine is given on the 3rd and 4th day after stem cell transplant. The standard dose of this medicine is 50 mg per kg of the patient's weight given on the 3rd and the 4th day. However, using this medicine at this dose of 50 mg / kg for 2 days is associated with certain problems such as susceptibility to infections and delay in the recovery of the immune system after stem cell transplant. Therefore, several research groups across the world have tried to reduce the d…

Sponsor: ଟାଟା ମେମୋରିଆଲ ସେଣ୍ଟର
ClinicalTrials.gov ରେ NCT07719946
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ 22 ଜୁଲାଇ 2026 · ଆମ ଦ୍ୱାରା ପଢାଯାଇଛି 20 ଅକ୍ଟୋବର 2026